Health technology strategies for advanced COPD: Evidence and Future Directions

Discover the impact of research in the latest RESP seminar on Wednesday 2 April, 7-8pm.

This insightful and educational session is the first of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK.

Hosted by Inspire, the webinar will feature expert speaker Professor Nick Hart and patient Chantal Davies.

Book your space here.

What they will cover:

• Current COPD management strategies
• Future directions based on the latest research
• Expert patient insights

This session will highlight the value of co-conceiving research ideas with patients, shaping impactful studies and strengthening funding applications.

Don't miss this chance to enhance your research approach and explore the future of COPD care!

This webinar is RCP CPD approved (code: 151134) for those who join the live webinar and complete the feedback form provided. Please note: Application for CPD approval has been submitted to the Federation of the Royal Colleges of Physicians of the UK.

Meet the Speakers

Professor Nick Hart
Professor Hart is currently Deputy Medical Director of the Heart, Lung and Critical Care Clinical Group. Previously, he directed the critical care response to the COVID-19 pandemic as the primary respiratory physician to Prime Minister Boris Johnson. A leading researcher in chronic respiratory disease and mechanical ventilation, he has established the Lane Fox Clinical Respiratory Physiology Research Centre and PhD programme, as well as serving as Joint Editor-in-Chief of Thorax. He was awarded the BTS Meritorious Service Award (2022) and is the Respiratory Theme Lead for the Guy’s & St Thomas’ NIHR Cardiorespiratory Healthtech Research Centre.

Chantal Davies
Chantal Davies was diagnosed with COPD/emphysema in 2010 following 11 weeks being intubated and a lengthy time in ICU.  During her rehabilitation, she joined Professor Hart on his team as a Public Patient representative at Lane Fox, St Thomas' hospital. Chantal describes the experience as meaningful as "it was my way of giving back to the NHS for all the great care I had had, and there was the hope that there would be future treatments for my condition." She is now in her eleventh year as a PPI member, not only for Lane Fox but for other Hospitals and Universities in the UK and has taken part in numerous clinical trials and studies such as March Trial, Delta ICU, EpiC-HPT and NAVA.